Explainable AI Framework for Precision Public Health in Metabolic Disorders: A Federated, Multi-Modal Predictive Modelling Approach for Early Detection and Intervention of Type 2 Diabetes

Main Article Content

Md Habibur Rahman
Md Nazibullah Khan
Sachin Das
Borhan Uddin

Abstract

One of the biggest public health problems of the twenty-first century is metabolic disorders, especially Type 2 diabetes (T2D). Morbidity, mortality, and medical expenses can be significantly decreased by early detection of at-risk people. However, nonlinear, multi-factorial, and high-dimensional interactions that influence the development of disease are not well captured by traditional risk-scoring methods. In order to predict and interpret the risk of type 2 diabetes and related metabolic disorders, this study creates an Explainable AI (XAI) framework for precision public health that combines multi-modal data, such as genomic profiles, lifestyle factors, socioeconomic determinants, and electronic health records (EHR). We create a federated, hybrid model that combines Random Forest classifiers, Deep Neural Networks (DNN), and Gradient Boosting Machines (LightGBM/XGBoost), building on federated and ensemble learning paradigms. Shapley Additive Explanations (SHAP) and counterfactual analysis are used to uncover personalized, actionable risk profiles in order to attain explainability. Harmonized multi-institutional datasets with over 200,000 records gathered from several U.S. health systems are used to train the model. The results show a calibrated Brier score of 0.12, sensitivity of 89%, specificity of 87%, and AUC of 0.93 ± 0.01. The socioeconomic deprivation index, polygenic risk score, BMI slope, and HbA1c trajectory are the main factors, according to SHAP study. Federated deployment protects data privacy while preserving performance. These results show that federated, explainable AI pipelines can facilitate population-based, privacy-preserving, andThe goal of precision public health is being advanced by large-scale early-warning systems for managing metabolic diseases.

Article Details

How to Cite
Rahman, M. H., Khan, M. N., Das, S., & Uddin, B. (2025). Explainable AI Framework for Precision Public Health in Metabolic Disorders: A Federated, Multi-Modal Predictive Modelling Approach for Early Detection and Intervention of Type 2 Diabetes. The Eastasouth Journal of Information System and Computer Science, 3(02), 164–178. https://doi.org/10.58812/esiscs.v3i02.759
Section
Articles

References

M. K. Ahmed et al., “Leveraging big data analytics for personalized cancer treatment: An overview of current approaches and future directions,” J. Eng., vol. 2025, no. 1, p. 9928467, 2025, [Online]. Available: https://doi.org/10.1155/je/9928467

M. M. T. G. Manik, “An Analysis of Cervical Cancer using the Application of AI and Machine Learning,” J. Med. Heal. Stud., vol. 3, no. 2, pp. 67–76, 2022, [Online]. Available: https://doi.org/10.32996/jmhs.2022.3.2.11

M. Manik et al., “Integrating genomic data and machine learning to advance precision oncology and targeted cancer therapies,” Nanotechnol. Perceptions, vol. 18, no. 2, pp. 219–243, 2022, [Online]. Available: https://doi.org/10.62441/nano-ntp.v18i2.5443

M. Moniruzzaman et al., “Big Data Strategies for Enhancing Transparency in U.S. Healthcare Pricing,” J. Posthumanism, vol. 5, no. 5 SE-, pp. 3744–3766, May 2025, doi: 10.63332/joph.v5i5.1813.

M. M. T. G. Manik et al., “AI-Driven Precision Medicine Leveraging Machine Learning and Big Data Analytics for Genomics-Based Drug Discovery,” J. Posthumanism, vol. 5, no. 1 SE-, pp. 1560–1580, Jan. 2025, doi: 10.63332/joph.v5i1.1993.

D. Dave, K. Vyas, J. K. Jayagopal, A. Garcia, M. Erraguntla, and M. Lawley, “FedGlu: A personalized federated learning-based glucose forecasting algorithm for improved performance in glycemic excursion regions,” arXiv Prepr. arXiv2408.13926, 2024, [Online]. Available: https://arxiv.org/abs/2408.13926

M. M. T. G. Manik, A. S. M. Saimon, M. K. Ahmed, S. Hossain, M. Moniruzzaman, and M. S. Islam, “Predictive Modelling for Early Detection of Type 2 Diabetes Using AI-Driven Machine Learning Algorithms and Big Data Analytics,” in International Conference on AI and Robotics, 2025, pp. 422–433. [Online]. Available: https://doi.org/10.1007/978-3-032-05548-4_33

M. M. T. G. Manik, “Integrative Analysis of Heterogeneous Cancer Data Using Autoencoder Neural Networks,” vol. 10, no. 3s, p. 2025, 2025, [Online]. Available: https://doi.org/10.52783/jisem.v10i3s.4746

K. D. Bennett and Y. Han, “Federated learning for biomedical research: Current challenges and future opportunities,” Nat. Mach. Intell., vol. 6, no. 2, pp. 158–169, 2024, [Online]. Available: https://doi.org/10.1038/s42256-024-00987-0

G. Cammarota et al., “Gut microbiome, big data and machine learning to promote precision medicine for cancer,” Nat. Rev. Gastroenterol. Hepatol., vol. 17, no. 10, pp. 635–648, 2020, [Online]. Available: https://doi.org/10.1038/s41575-020-0296-7

E. Capobianco, “High-dimensional role of AI and machine learning in cancer research,” Br. J. Cancer, vol. 126, no. 4, pp. 523–532, 2022, [Online]. Available: https://doi.org/10.1038/s41416-021-01637-z

R. J. Chen, M. Y. Lu, T. Y. Chen, and F. Mahmood, “Multimodal deep learning in computational pathology and metabolic oncology,” Nat. Biomed. Eng., vol. 7, no. 5, pp. 549–562, 2023, [Online]. Available: https://doi.org/10.1038/s41551-022-00933-0

M. A. Miah, E. Rozario, F. B. Khair, M. K. Ahmed, M. M. R. Bhuiyan, and M. Manik, “Harnessing wearable health data and deep learning algorithms for real-time cardiovascular disease monitoring and prevention,” Nanotechnol. Perceptions, vol. 15, no. 3, pp. 326–349, 2019.

E. Topol, “High-performance medicine: the convergence of human and artificial intelligence,” Nat. Med., vol. 25, Jan. 2019, doi: 10.1038/s41591-018-0300-7.

S. Dash, S. K. Shakyawar, M. Sharma, and S. Kaushik, “Big data in healthcare: management, analysis and future prospects,” J. big data, vol. 6, no. 1, pp. 1–25, 2019, [Online]. Available: https://doi.org/10.1186/s40537-019-0217-0

S. M. Lundberg and S. I. Lee, “A unified approach to interpreting model predictions,” Adv. Neural Inf. Process. Syst., vol. 2017-Decem, no. Section 2, pp. 4766–4775, 2017.

M. S. Islam et al., “Explainable AI in Healthcare: Leveraging Machine Learning and Knowledge Representation for Personalized Treatment Recommendations,” J. Posthumanism, vol. 5, no. 1 SE-, pp. 1541–1559, Jan. 2025, doi: 10.63332/joph.v5i1.1996.

M. T. Ribeiro, S. Singh, and C. Guestrin, “Beyond accuracy: Model explanations and human–AI collaboration in healthcare,” J. Artif. Intell. Res., vol. 75, pp. 127–154, 2022, [Online]. Available: https://doi.org/10.1613/jair.1.13782

F. H. Yagin, C. Colak, A. Algarni, Y. Gormez, E. Guldogan, and L. P. Ardigò, “Hybrid explainable artificial intelligence models for targeted metabolomics analysis of diabetic retinopathy,” Diagnostics, vol. 14, no. 13, p. 1364, 2024, [Online]. Available: https://doi.org/10.3390/diagnostics14131364

P. Kairouz et al., “Advances and open problems in federated learning,” Found. trends® Mach. Learn., vol. 14, no. 1–2, pp. 1–210, 2021, [Online]. Available: https://doi.org/10.1561/2200000083

S. M. Orthi et al., “Federated learning with privacy-preserving big data analytics for distributed healthcare systems,” J. Comput. Sci. Technol. Stud., vol. 7, no. 8, pp. 269–281, 2025, [Online]. Available: https://doi.org/10.32996/jcsts.2025.7.8.31

M. Chetoui and M. A. Akhloufi, “Federated Learning for Diabetic Retinopathy Detection Using Vision Transformers,” BioMedInformatics, vol. 3, no. 4, pp. 948–961, 2023, doi: 10.3390/biomedinformatics3040058.

Y. Xu, J. Zhang, and Y. Gu, “Privacy-preserving heterogeneous federated learning for sensitive healthcare data,” in 2024 IEEE Conference on Artificial Intelligence (CAI), 2024, pp. 1142–1147. [Online]. Available: https://arxiv.org/abs/2406.10563

Y. Zhou, Q. Liu, and J. Chen, “Federated explainable learning for healthcare: Aggregating local SHAP at global scale,” IEEE J. Biomed. Heal. Informatics, vol. 26, no. 11, pp. 5492–5503, 2022, [Online]. Available: https://doi.org/10.1109/JBHI.2022.3187421

P. Braveman, E. Arkin, D. Proctor, E. Kahle, and S. Levine, “Systemic inequities and health disparities: A conceptual framework,” Annu. Rev. Public Health, vol. 43, pp. 37–55, 2022, [Online]. Available: https://doi.org/10.1146/annurev-publhealth-042921-014153

M. Manik et al., “Leveraging AI-powered predictive analytics for early detection of chronic diseases: A data-driven approach to personalized medicine,” Nanotechnol. Perceptions, vol. 17, no. 3, pp. 269–288, 2021, [Online]. Available: https://doi.org/10.62441/nano-ntp.v17i3.5444

K. Mishra et al., “Predicting Diabetes with Federated Learning: A Digital Twin and Medical Fog-based IoT Framework,” ACM Trans. Internet Technol., Feb. 2025, doi: 10.1145/3711859.